Clinical Trials Logo

Joint Diseases clinical trials

View clinical trials related to Joint Diseases.

Filter by:
  • Active, not recruiting  
  • « Prev · Page 7

NCT ID: NCT02036931 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System

Start date: March 2013
Phase:
Study type: Observational

The primary purpose of this study is to evaluate the clinical and radiographic performance of the G7 Acetabular Cup System.

NCT ID: NCT01754363 Active, not recruiting - Clinical trials for Noninflammatory Degenerative Joint Disease

Survivorship of Attune Primary Total Knee Prosthesis

Start date: February 1, 2013
Phase: N/A
Study type: Interventional

This post-marketing investigation will evaluate the long term (up to 15 years) survivorship of the Attune Primary Knee Prosthesis in patients with non-inflammatory degenerative joint disease. Data from Subjects who receive one of four knee configurations will be pooled to establish a contemporary dataset.

NCT ID: NCT01700543 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Sidus(TM) Post Market Clinical Follow-up (PMCF) Study

Start date: October 2012
Phase:
Study type: Observational

This post market clinical follow-up study is designed to confirm safety and performance of the Sidus Stem-Free Shoulder when used in hemi or total shoulder arthroplasty. The safety of the implant will be evaluated by monitoring the frequency and incidence of all kinds of adverse events. The performance will be determined by analyzing the implant survival, overall pain and functional performances (based on Constant & Murley score and ASES score), subject quality of life (EuroQol EQ5D) and radiographic parameters (e.g. radiolucencies, osteolysis, component migration) of study subjects who received the Sidus Stem-Free Shoulder. The Sidus Stem-Free Shoulder is not approved for use in the US.

NCT ID: NCT01417650 Active, not recruiting - Clinical trials for Temporomandibular Joint Disorder

The Effect of Low Level Laser Therapy on Improvement of Temporomandibular Joint Osteoarthritis

Start date: January 2011
Phase: N/A
Study type: Interventional

Temporomandibular disorder (TMD) is the major cause of nondental pain in orofacial area. Laser therapy can be considered as one of the most popular methods of pain relief in TMD patients. The special features of laser light such as coherence, monochromaticity, and collimation can result in the ability of laser light to modify cellular metabolism, increase tissue repair and reduce edema and inflammation. The effectiveness of low level laser therapy in reducing the signs and symptoms of temporomandibular joint disorders has been investigated in a few studies. But, in most of the previous studies the etiology of TMD has not been considered in patient selection. Furthermore, there are some controversies in the results of these studies. According to our data, there is no study evaluating the effects of low level laser therapy on patients having TMJ osteoarthritis. The aim of this study is to evaluate the effectiveness of low level laser therapy in improving osteoarthritis of temporomandibular joint and also to evaluate the long term effects of laser therapy on the morphology of the joint.

NCT ID: NCT01121952 Active, not recruiting - Clinical trials for Talo-crural Joint Dysfunction

The Effect of Manipulation on Dysfunction of the Talo-crural Joint

Start date: November 2009
Phase: N/A
Study type: Interventional

The purpose of this trial was to explore the effects of chiropractic manipulation in patients with talo-crural joint dysfunction.

NCT ID: NCT00977444 Active, not recruiting - Osteoarthritis Clinical Trials

Evaluation of a New Formulation Useful for the Osteoarthrosis Treatment

EFO
Start date: November 2007
Phase: Phase 2/Phase 3
Study type: Interventional

Abstract Kondrium, is a pharmaceutical composition for the treatment of osteoarthritis (OA). This study was designed to evaluate the efficacy and safety of kondrium in the treatment of OA of knee. A 3 month, randomized, double-blind, active-controlled, parallel-group study will be carried out. 117 patients with OA of the knee will be randomized to receive 1 intra-articular monthly injection of 5 mL of one of the following: 75 mg/mL of Kondrium, 82.5 mg/mL of Kondriumf or 8 mg/mL of methylprednisolone once a month during 3 months. The primary efficacy variable will be the change from baseline to final assessment in the Western Ontario and McMaster University OA index (WOMAC subscale score for pain), and Lequesne´s functional index.